Related references
Note: Only part of the references are listed.Impact of adjuvant chemotherapy and patient age on patterns of metastatic recurrence in stage III colorectal cancer.
Grace Gard et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Active surveillance of patients who have sentinel node positive melanoma: An international, multi-institution evaluation of adoption and early outcomes after the Multicenter Selective Lymphadenectomy trial II (MSLT-2)
Kristy Kummerow Broman et al.
CANCER (2021)
Adjuvant Therapy is Effective for Melanoma Patients with a Positive Sentinel Lymph Node Biopsy Who Forego Completion Lymphadenectomy
Norma E. Farrow et al.
ANNALS OF SURGICAL ONCOLOGY (2020)
Adjuvant Therapy Failure Patterns in the Modern Era of Melanoma Management
Daan Jan Willem Rauwerdink et al.
ANNALS OF SURGICAL ONCOLOGY (2020)
Management of the positive sentinel lymph node in the post-MSLT-II era
Brooke C. Bredbeck et al.
JOURNAL OF SURGICAL ONCOLOGY (2020)
Final Analysis of DeCOG-SLT Trial: No Survival Benefit for Complete Lymph Node Dissection in Patients With Melanoma With Positive Sentinel Node
Ulrike Leiter et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Dabrafenib plus trametinib versus dabrafenib monotherapy in patients with metastatic BRAF V600E/K-mutant melanoma: long-term survival and safety analysis of a phase 3 study
G V Long et al.
ANNALS OF ONCOLOGY (2019)
Novel patterns of response under immunotherapy
E. Borcoman et al.
ANNALS OF ONCOLOGY (2019)
Updates in adjuvant systemic therapy for melanoma
Minyoung Kwak et al.
JOURNAL OF SURGICAL ONCOLOGY (2019)
Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma
Alexander M. M. Eggermont et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
The impact of adjuvant therapies on patient survival and the recurrence patterns for resected stage IIa-IVa lower thoracic oesophageal squamous cell carcinoma
Yichun Wang et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2018)
Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma
J. Weber et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma
M. B. Faries et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Complete lymph node dissection versus no dissection in patients with sentinel lymph node biopsy positive melanoma (DeCOG-SLT): a multicentre, randomised, phase 3 trial
Ulrike Leiter et al.
LANCET ONCOLOGY (2016)
Prolonged Survival in Stage III Melanoma with Ipilimumab Adjuvant Therapy
A. M. M. Eggermont et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Stage-specific survival and recurrence in patients with cutaneous malignant melanoma in Europe - a systematic review of the literature
Fernanda Costa Svedman et al.
CLINICAL EPIDEMIOLOGY (2016)
Adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): a randomised, double-blind, phase 3 trial
Alexander M. M. Eggermont et al.
LANCET ONCOLOGY (2015)
Contemporary Diagnostic Imaging Modalities for the Staging and Surveillance of Melanoma Patients: a Meta-analysis
Yan Xing et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
Share Paper
